Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®

Philippe Halfon,1,2 Sophie Ravet,3 Hacène Khiri,1 Guillaume Penaranda,1,2,3 and Carole Lefoll2

1 Laboratoire Alphabio, Marseille, France
2 Hopital Ambroise Paré, Marseille, France
3 CDL Pharma, Marseille, France
Corresponding author email: philippe.halfon@alphabio.fr
This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.

Abstract

We report the case of a 19-year-old woman who received a complete vaccine program by Gardasil. After one year, Greiner HPV test revealed HPV51 positivity. This case report highlights the limits of the vaccine, and the need to have a clinical follow up of patients despite the vaccination program.

Access entire article here.

Speak Your Mind

*

*